Regeneron Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 288 U.S.-traded ETFs. REGN has around 12.0M shares in the U.S. ETF market. The largest ETF holder of REGN is the Invesco QQQ Trust (QQQ), with approximately 1.52M shares. Investors may also find of interest that the ETF with the largest allocation to REGN stock is Invesco Nasdaq Biotechnology ETF (IBBQ), with a portfolio weight of 7.02%. On average, U.S. ETFs allocate 0.90% of REGN to their portfolios.
Additionally, REGN is a favorite stock for Active and Vanilla ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with REGN as a holding is the ProShares Ultra QQQ (QLD), with a return of 70.08%.